Sponsor Dossier
Phebra
Sponsor Dossier for Phebra. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABBOTT
- Brand: ACETADOTE
- Brand: ARAMINE
- Brand: ARGININE
- Brand: ASTRAZENECA
- Brand: Balanced
- Brand: BENZATROPINE INJECTION
- Brand: BENZTROP
- Device (sponsor): Cryogenic spray, cutaneous
About
Phebra is an Australian Private Company with ABN 99059357890, registered in NSW and currently active.
Portfolio
Phebra has 51 brands on the ARTG, with 37 indexable brands and 36 brands with Product Information on file. Eight brands have at least one PBS-listed item, four brands have PBAC outcomes on record, and three brands have AusPARs on record.
Therapeutic focus
— Cardiology: 5 brands — Oncology: 5 brands — Neurology: 4 brands — Pain & Anaesthesia: 4 brands — Pain Management: 4 brands — Other: 4 brands — Ophthalmology: 3 brands — Endocrinology: 3 brands — Infectious Disease: 3 brands — Haematology: 3 brands — Urology: 2 brands — Women's Health: 2 brands — Reproductive Health: 2 brands — Complementary Medicine: 1 brand — Renal: 1 brand — Dermatology: 1 brand — Respiratory: 1 brand — Psychiatry: 1 brand — Gastroenterology: 1 brand — Uncategorised: 1 brand
PBS footprint
Eight brands in the Phebra portfolio are PBS-listed, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
The latest PBAC outcome on record is from 2019-07-01, with four brands having PBAC outcomes. The latest AusPAR is from 2015-08-24, with three brands holding AusPARs on record.